Opko Sees Huge Long-Term Impact From Prolor Deal

Aug. 21 (Bloomberg) -- Phillip Frost, chief executive officer of Opko Health Inc., talks about its share listing on the Tel Aviv Stock Exchange today and the acquisition of Israeli drugmaker Prolor Biotech Inc. He speaks with Elliott Gotkine on Bloomberg Television's "On the Move." (Source: Bloomberg)
The Top Stocks to Watch in Asia Today
21:00 - In today’s “Stock Exchange,” Bloomberg’s Yvonne Man and Shery Ahn discuss the top stocks to watch in Asia on “First Up.” (Source: Bloomberg)
  • Japanese Market Is Showing Signs of Life: Dagan
  • Hanergy's Li Increased Short Position Before Stock Crash
  • Greece Calls on Creditors to Compromise